| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8668299 | Journal of Clinical Lipidology | 2018 | 19 Pages |
Abstract
- Commentary on use of PCSK9 monoclonal antibodies in familial hypercholesterolemia.
- Comment on recent analysis from the SPIRE clinical trial program.
- Future treatment options in patients with familial hypercholesterolemia.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Natalie C. PhD, Gerald F. DSc, MD, PhD,